Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

Complement Activation and Thrombotic Microangiopathies.

Palomo M, Blasco M, Molina P, Lozano M, Praga M, Torramade-Moix S, Martinez-Sanchez J, Cid J, Escolar G, Carreras E, Paules C, Crispi F, Quintana LF, Poch E, Rodas L, Goma E, Morelle J, Espinosa M, Morales E, Avila A, Cabello V, Ariceta G, Chocron S, Manrique J, Barros X, Martin N, Huerta A, Fraga-Rodriguez GM, Cao M, Martin M, Romera AM, Moreso F, Manonelles A, Gratacos E, Pereira A, Campistol JM, Diaz-Ricart M.

Clin J Am Soc Nephrol. 2019 Dec 6;14(12):1719-1732. doi: 10.2215/CJN.05830519. Epub 2019 Nov 6.

PMID:
31694864
2.

Severe and malignant hypertension are common in primary atypical hemolytic uremic syndrome.

Cavero T, Arjona E, Soto K, Caravaca-Fontán F, Rabasco C, Bravo L, de la Cerda F, Martín N, Blasco M, Ávila A, Huerta A, Cabello V, Jarque A, Alcázar C, Fulladosa X, Carbayo J, Anaya S, Cobelo C, Ramos N, Iglesias E, Baltar J, Martínez-Gallardo R, Pérez L, Morales E, González R, Macía M, Draibe J, Pallardó L, Quintana LF, Espinosa M, Barros X, Pereira F, Cao M, Moreno JA, Rodríguez de Córdoba S, Praga M; Spanish Group for the Study of Glomerular Diseases (GLOSEN).

Kidney Int. 2019 Oct;96(4):995-1004. doi: 10.1016/j.kint.2019.05.014. Epub 2019 May 31.

PMID:
31420192
3.

Six-2 glomerular expression for the prediction of renal outcome in systemic amyloidosis.

Rodas LM, Garcia-Herrera A, Ramirez Bajo M, Fernandez-Larrea C, Cibeira MT, Blasco M, Rosiñol L, Solé M, Blade J, Campistol JM, Quintana LF.

Amyloid. 2019;26(sup1):97-98. doi: 10.1080/13506129.2019.1582483. No abstract available.

PMID:
31343337
4.

IgA Nephropathy in Elderly Patients.

Sevillano AM, Diaz M, Caravaca-Fontán F, Barrios C, Bernis C, Cabrera J, Calviño J, Castillo L, Cobelo C, Delgado-Mallén P, Espinosa M, Fernandez-Juarez G, Fernandez-Reyes MJ, Garcia-Osuna R, Garcia P, Goicoechea M, Gonzalez-Cabrera F, Guzmán DA, Heras M, Martín-Reyes G, Martinez A, Olea T, Peña JK, Quintana LF, Rabasco C, López Revuelta K, Rodas L, Rodriguez-Mendiola N, Rodriguez E, San Miguel L, Sanchez de la Nieta MD, Shabaka A, Sierra M, Valera A, Velo M, Verde E, Ballarin J, Noboa O, Moreno JA, Gutiérrez E, Praga M; Spanish Group for the Study of Glomerular Diseases (GLOSEN).

Clin J Am Soc Nephrol. 2019 Aug 7;14(8):1183-1192. doi: 10.2215/CJN.13251118. Epub 2019 Jul 16.

PMID:
31311818
5.

ANCA associated vasculitis: The journey to complement-targeted therapies.

Quintana LF, Kronbichler A, Blasco M, Zhao MH, Jayne D.

Mol Immunol. 2019 Aug;112:394-398. doi: 10.1016/j.molimm.2019.06.018. Epub 2019 Jul 7. Review.

PMID:
31291610
6.

Postinfectious Acute Glomerulonephritis in Renal Transplantation: An Emergent Aetiology of Renal Allograft Loss.

Molina-Andújar A, Montagud-Marrahí E, Cucchiari D, Ventura-Aguiar P, De Sousa-Amorim E, Revuelta I, Cofan F, Solé M, García-Herrera A, Diekmann F, Poch E, Quintana LF.

Case Rep Transplant. 2019 Mar 18;2019:7438254. doi: 10.1155/2019/7438254. eCollection 2019.

7.

Post-splenectomy acute glomerulonephritis due to a chronic infection with Plasmodium falciparum and malariae.

Camprubí D, Balerdi L, Quintana LF, Almuedo-Riera A, Valls ME, García-Herrera A, Rodriguez-Valero N, Alvarez-Martínez MJ, Muñoz J.

J Travel Med. 2019 Jun 1;26(4). pii: taz029. doi: 10.1093/jtm/taz029. No abstract available.

PMID:
30995305
8.

Onco-Nephrology: Cancer, chemotherapy and kidney.

de Francisco ALM, Macía M, Alonso F, García P, Gutierrez E, Quintana LF, Quiroga B, Torregrosa I.

Nefrologia. 2019 Sep - Oct;39(5):473-481. doi: 10.1016/j.nefro.2018.10.016. Epub 2019 Mar 29. Review. English, Spanish.

9.

Refractory lupus nephritis: When, why and how to treat.

Kronbichler A, Brezina B, Gauckler P, Quintana LF, Jayne DRW.

Autoimmun Rev. 2019 May;18(5):510-518. doi: 10.1016/j.autrev.2019.03.004. Epub 2019 Mar 4. Review.

PMID:
30844548
10.

Antiphospholipase 2 receptor antibody levels to predict complete spontaneous remission in primary membranous nephropathy.

Rodas LM, Matas-García A, Barros X, Blasco M, Viñas O, Llobell A, Martin N, Quintana LF.

Clin Kidney J. 2019 Feb;12(1):36-41. doi: 10.1093/ckj/sfy005. Epub 2018 Mar 9.

11.

The utility of phospholipase A2 receptor autoantibody in membranous nephropathy after kidney transplantation.

Xipell M, Rodas LM, Villarreal J, Molina A, Reinoso-Moreno J, Blasco M, Poch E, Diekmann F, Campistol JM, Quintana LF.

Clin Kidney J. 2018 Jun;11(3):422-428. doi: 10.1093/ckj/sfx128. Epub 2017 Nov 22.

12.

Acute tubulointerstitial nephritis associated with atezolizumab, an anti-programmed death-ligand 1 (pd-l1) antibody therapy.

Xipell M, Victoria I, Hoffmann V, Villarreal J, García-Herrera A, Reig O, Rodas L, Blasco M, Poch E, Mellado B, Quintana LF.

Oncoimmunology. 2018 Mar 26;7(7):e1445952. doi: 10.1080/2162402X.2018.1445952. eCollection 2018.

13.

Determinants of renal and patient outcomes in a Spanish cohort of patients with ANCA-associated vasculitis and renal involvement.

Marco H, Draibe J, Villacorta J, Quintana LF, Martin N, Garcia-Osuna R, Cabre C, Martín-Gómez MA, Balius A, Saurina A, Picazo M, Gich-Saladich I, Navarro-Díaz M, Praga M, Cavero T, Ballarin J, Díaz-Encarnación MM; Spanish Group for the Study of Glomerular Disease (GLOSEN).

Clin Rheumatol. 2018 Apr;37(4):1065-1074. doi: 10.1007/s10067-017-3973-2. Epub 2018 Mar 9.

PMID:
29520673
14.

Clinical impact of regional citrate anticoagulation in continuous renal replacement therapy in critically ill patients.

Huguet M, Rodas L, Blasco M, Quintana LF, Mercadal J, Ortiz-Pérez JT, Rovira I, Poch E.

Int J Artif Organs. 2017 Nov 24;40(12):676-682. doi: 10.5301/ijao.5000633. Epub 2017 Aug 17.

PMID:
28862718
15.

Elevated factor H-related protein 1 and factor H pathogenic variants decrease complement regulation in IgA nephropathy.

Tortajada A, Gutiérrez E, Goicoechea de Jorge E, Anter J, Segarra A, Espinosa M, Blasco M, Roman E, Marco H, Quintana LF, Gutiérrez J, Pinto S, Lopez-Trascasa M, Praga M, Rodriguez de Córdoba S.

Kidney Int. 2017 Oct;92(4):953-963. doi: 10.1016/j.kint.2017.03.041. Epub 2017 Jun 19.

PMID:
28637589
16.

Eculizumab in secondary atypical haemolytic uraemic syndrome.

Cavero T, Rabasco C, López A, Román E, Ávila A, Sevillano Á, Huerta A, Rojas-Rivera J, Fuentes C, Blasco M, Jarque A, García A, Mendizabal S, Gavela E, Macía M, Quintana LF, María Romera A, Borrego J, Arjona E, Espinosa M, Portolés J, Gracia-Iguacel C, González-Parra E, Aljama P, Morales E, Cao M, Rodríguez de Córdoba S, Praga M.

Nephrol Dial Transplant. 2017 Mar 1;32(3):466-474. doi: 10.1093/ndt/gfw453.

17.

Systemic lupus erythematous exacerbation following cessation of belimumab treatment: comments on the article by Furer et al.

Carbajal S, Zamora-Martínez C, Prieto-González S, Quintana LF, Espinosa G, Cervera R.

Scand J Rheumatol. 2017 May;46(3):250-251. doi: 10.1080/03009742.2016.1264626. Epub 2017 Feb 16. No abstract available.

PMID:
28276955
18.

Pre-transplant phospholipase A2 receptor autoantibody concentration is associated with clinically significant recurrence of membranous nephropathy post-kidney transplantation.

Gupta G, Fattah H, Ayalon R, Kidd J, Gehr T, Quintana LF, Kimball P, Sadruddin S, Massey HD, Kumar D, King AL, Beck LH Jr.

Clin Transplant. 2016 Apr;30(4):461-9. doi: 10.1111/ctr.12711. Epub 2016 Mar 11.

PMID:
26854647
19.

Sustained remission in lupus nephritis: still a hard road ahead.

Quintana LF, Jayne D.

Nephrol Dial Transplant. 2016 Dec;31(12):2011-2018. Epub 2015 Nov 19. Review.

PMID:
26590267
20.

Efficacy of plasma exchange and immunoadsorption in systemic lupus erythematosus and antiphospholipid syndrome: A systematic review.

Kronbichler A, Brezina B, Quintana LF, Jayne DR.

Autoimmun Rev. 2016 Jan;15(1):38-49. doi: 10.1016/j.autrev.2015.08.010. Epub 2015 Aug 28. Review.

PMID:
26318215
21.

Antiphospholipase A2 Receptor Antibody Levels Predict the Risk of Posttransplantation Recurrence of Membranous Nephropathy.

Quintana LF, Blasco M, Seras M, Pérez NS, López-Hoyos M, Villarroel P, Rodrigo E, Viñas O, Ercilla G, Diekmann F, Gómez-Roman JJ, Fernandez-Fresnedo G, Oppenheimer F, Arias M, Campistol JM.

Transplantation. 2015 Aug;99(8):1709-14. doi: 10.1097/TP.0000000000000630.

PMID:
25675198
22.

[Interferon ß, nephrotic syndrome and thrombotic microangiopathy].

Quintana LF, Campistol JM.

Med Clin (Barc). 2015 Jan 20;144(2):65-6. doi: 10.1016/j.medcli.2014.09.008. Epub 2014 Nov 20. Spanish. No abstract available.

PMID:
25458512
23.

ANCA serotype and histopathological classification for the prediction of renal outcome in ANCA-associated glomerulonephritis.

Quintana LF, Peréz NS, De Sousa E, Rodas LM, Griffiths MH, Solé M, Jayne D.

Nephrol Dial Transplant. 2014 Sep;29(9):1764-9. doi: 10.1093/ndt/gfu084. Epub 2014 Apr 19.

PMID:
24748668
24.

Long-term mycophenolate monotherapy in human leukocyte antigen (HLA)-identical living-donor kidney transplantation.

Gascó B, Revuelta I, Sánchez-Escuredo A, Blasco M, Cofán F, Esforzado N, Quintana LF, Ricart MJ, Torregrosa JV, Campistol JM, Oppenheimer F, Diekmann F.

Transplant Res. 2014 Feb 3;3(1):4. doi: 10.1186/2047-1440-3-4.

25.

Influence of renal replacement therapy on immune response after one and two doses of the A(H1N1) pdm09 vaccine.

Quintana LF, Serra N, De Molina-Llauradó P, Blasco M, Martinez M, Campos B, Bayas JM, Pumarola T, Campistol JM.

Influenza Other Respir Viruses. 2013 Sep;7(5):809-14. doi: 10.1111/irv.12024. Epub 2012 Oct 19.

26.

Lymphoplasmacytic lymphoma causing light chain cast nephropathy.

Pérez NS, Garcia-Herrera A, Rosiñol L, Palos L, Santiago E, Espinosa G, Solé M, Campistol JM, Quintana LF.

Nephrol Dial Transplant. 2012 Jan;27(1):450-3. doi: 10.1093/ndt/gfr730. Epub 2012 Jan 11.

PMID:
22241794
27.

B-cell depleting agents for ANCA vasculitides: a new therapeutic approach.

Gómez-Puerta JA, Quintana LF, Stone JH, Ramos-Casals M, Bosch X.

Autoimmun Rev. 2012 Jul;11(9):646-52. doi: 10.1016/j.autrev.2011.11.007. Epub 2011 Nov 21. Review.

PMID:
22146313
28.

Mixed cryoglobulinaemia not related to hepatitis C virus, mesangiocapillary glomerulonephritis and lymphoplasmocytic lymphoma.

Martina MN, Solé M, Massó E, Pérez N, Campistol JM, Quintana LF.

Nefrologia. 2011;31(6):743-6. doi: 10.3265/Nefrologia.pre2011.Aug.10965. English, Spanish.

29.

Acute renal failure due to oxalate crystal deposition and enteric hyperoxaluria.

Sentís A, Quintana LF, Massó E, Peréz NS, Botey Puig A, Campistol Plana JM.

Nefrologia. 2011;31(1):121-3. doi: 10.3265/Nefrologia.pre2010.Oct.10644. No abstract available.

30.

Two-dimensional difference gel electrophoresis urinary proteomic profile in the search of nonimmune chronic allograft dysfunction biomarkers.

Bañón-Maneus E, Diekmann F, Carrascal M, Quintana LF, Moya-Rull D, Bescós M, Ramírez-Bajo MJ, Rovira J, Gutierrez-Dalmau A, Solé-González A, Abián J, Campistol JM.

Transplantation. 2010 Mar 15;89(5):548-58. doi: 10.1097/TP.0b013e3181c690e3.

PMID:
20134395
31.

Urine proteomics biomarkers in renal transplantation: an overview.

Quintana LF, Bañon-Maneus E, Solé-Gonzalez A, Campistol JM.

Transplantation. 2009 Aug 15;88(3 Suppl):S45-9. doi: 10.1097/TP.0b013e3181af7cba. Review.

PMID:
19667961
32.

Mammalian target of rapamycin inhibition prevents glomerular hypertrophy in a model of renal mass reduction.

Rovira J, Arellano EM, Carreras J, Campos B, Vodenik B, Bañón-Maneus E, Ramírez-Bajo MJ, Moya-Rull D, Solé-González A, Hernández A, Revuelta I, Quintana LF, Howat WJ, Campistol JM, Diekmann F.

Transplantation. 2009 Sep 15;88(5):646-52. doi: 10.1097/TP.0b013e3181b24463.

PMID:
19741461
33.

Application of label-free quantitative peptidomics for the identification of urinary biomarkers of kidney chronic allograft dysfunction.

Quintana LF, Campistol JM, Alcolea MP, Bañon-Maneus E, Sol-González A, Cutillas PR.

Mol Cell Proteomics. 2009 Jul;8(7):1658-73. doi: 10.1074/mcp.M900059-MCP200. Epub 2009 Apr 7.

34.

Urine proteomics to detect biomarkers for chronic allograft dysfunction.

Quintana LF, Solé-Gonzalez A, Kalko SG, Bañon-Maneus E, Solé M, Diekmann F, Gutierrez-Dalmau A, Abian J, Campistol JM.

J Am Soc Nephrol. 2009 Feb;20(2):428-35. doi: 10.1681/ASN.2007101137. Epub 2008 Dec 3.

35.

Effect of mTOR inhibitor on body weight: from an experimental rat model to human transplant patients.

Rovira J, Marcelo Arellano E, Burke JT, Brault Y, Moya-Rull D, Bañón-Maneus E, Ramírez-Bajo MJ, Gutiérrez-Dalmau A, Revuelta I, Quintana LF, Campistol JM, Diekmann F.

Transpl Int. 2008 Oct;21(10):992-8. doi: 10.1111/j.1432-2277.2008.00710.x. Epub 2008 Jul 24.

36.

[Baclofen-associated encephalopathy in a hemodialysis patient with hiccups].

Quintana LF, Lladó A, Butjosa M, Santamaría J, Torras A, Poch E.

Nefrologia. 2006;26(4):486-8. Spanish.

37.

A coding polymorphism in the 12-lipoxygenase gene is associated to essential hypertension and urinary 12(S)-HETE.

Quintana LF, Guzmán B, Collado S, Clària J, Poch E.

Kidney Int. 2006 Feb;69(3):526-30.

38.

Renal cortical necrosis after kidney transplantation associated with the prothrombin 20210A mutation.

Quintana LF, Cofan F, Reverté JC, Oppenheimer F, Campistol JM.

Nephrol Dial Transplant. 2006 May;21(5):1455-6. Epub 2005 Dec 15. No abstract available.

PMID:
16357049
39.

[Recurrent vascular access trombosis associated with the prothrombin mutation G20210A in a adult patient in haemodialysis].

Quintana LF, Coll E, Monteagudo I, Collado S, López-Pedret J, Cases A.

Nefrologia. 2005;25(4):442-4. Spanish.

40.

[Cytomegalovirus esophagitis in a patient on peritoneal dyalisis].

Quintana LF, Collado S, Coll E, López-Pedret J, Cases A.

Nefrologia. 2005;25(2):201-4. Spanish.

Supplemental Content

Loading ...
Support Center